AOD 9604 (6mg)

• AOD 9604 is a modified fragment of human growth hormone (hGH), specifically the C-terminal fragment (amino acids 176–191).
• Unlike full hGH, it does not raise IGF-1 levels, meaning it doesn’t have the growth-promoting effects of HGH.
• It works by:
• Stimulating lipolysis → breaks down stored fat.
• Inhibiting lipogenesis → prevents new fat from forming.
• Primarily targets adipose tissue, especially stubborn fat deposits, rather than muscle or organs.

Clinical and anecdotal reports suggest:

• Fat reduction (especially abdominal fat)
• Improved lipid metabolism (enhances fat breakdown and use for energy)
• Supports weight management when paired with diet & exercise
• Does not affect blood sugar significantly (unlike some fat-loss drugs)
• No effect on IGF-1 → considered safer than HGH in terms of growth/tumor risk

Generally well-tolerated, but possible effects include:

• Headache

• Nausea or gastrointestinal upset

• Mild joint pain or muscle stiffness

• Localized redness/swelling at injection site

• Rare: palpitations, mood changes, or fluid retention

AOD 9604 should be avoided or used cautiously in:

• Pregnant or breastfeeding women (safety not established)
• Children/adolescents (not approved for growth or obesity treatment in minors)
• Cancer patients → though it doesn’t raise IGF-1, caution is advised since it’s a HGH fragment
• Severe medical conditions (cardiac disease, uncontrolled hypertension, severe liver/kidney dysfunction) without medical supervision
• People allergic to peptide formulations

AOD 9604 is a fat-targeting peptide designed to mimic the weight loss–related effects of growth hormone without its unwanted growth effects. It’s not a magic bullet, but when combined with healthy diet and exercise, it may support fat loss with fewer risks than HGH.